Vaxxas Publication in PLoS Medicine Reveals Groundbreaking Clinical Research on Broad Potential of Novel High-Density Microarray Patch (HD-MAP) Media ReleaseCarolyn MillerMarch 17, 2020Vaxxas, Paul Kelly
OneVentures invests in international software company Phocas, bringing business back to Australia and positioning the company for international expansion Media ReleaseCarolyn MillerMarch 16, 2020Phocas, Michelle Deaker, Grant Chamberlain
Pearson acquires interactive learning technology from Smart Sparrow Media ReleaseCarolyn MillerJanuary 16, 2020Smart Sparrow, Grant Chamberlain
iStaySafe Acquires Find-Me Technologies, Strengthens position in the IoT Industry Media ReleaseCarolyn MillerNovember 6, 2019Find-Me Technologies, Anne-Marie Birkill
Immunology Company Kira Biotech launches with $20M Series A Funding Media ReleaseCarolyn MillerOctober 29, 2019Kira Biotech, Paul Kelly
Blade Therapeutics announces publication of preclinical data supporting Calpain 9 as a promising therapeutic target for fibriotic disease Media ReleaseCarolyn MillerAugust 21, 2019Paul Kelly, Blade Therapeutics
Leading Airbnb Property Management Company, Hometime, announces $6M funding round with OneVentures, in inaugural venture debt deal Media ReleaseCarolyn MillerJune 18, 2019Michelle Deaker
OneVentures reaches first close of Australia’s first venture credit fund Media ReleaseCarolyn MillerApril 8, 2019Michelle Deaker, Grant Chamberlain
VC-backed women’s health company Madorra to begin clinical trials in Australia Media ReleaseCarolyn MillerSeptember 17, 2018Anne-Marie Birkill, Madorra
OneVentures invests in regional Queensland company developing treatments for autoimmune diseases Media ReleaseCarolyn MillerAugust 14, 2018Anne-Marie Birkill, Paragen Bio
Australian First:-Israeli venture partnership launches new Venture Credit Fund to invest in high-growth technology companies Media ReleaseCarolyn MillerAugust 6, 2018Michelle Deaker
Prota/MCRI completes enrolment of Phase 2b multicentre clinical trial of probiotic oral immunotherapy for the treatment of peanut allergy (PPOIT-003) Media ReleaseCarolyn MillerMay 23, 2018Prota Therapeutics, Paul Kelly
Biomedical Translation Fund invests in further development of total artificial heart device Media ReleaseCarolyn MillerMay 17, 2018BiVACOR, Paul Kelly, OneVentures
Prota Therapeutics partners with world leading bioscience company, Chr. Hansen Media ReleaseCarolyn MillerApril 19, 2018Paul Kelly, Prota Therapeutics, OneVentures
OneVentures’ Investee Smart Sparrow Secures Strategic Investment from Global Education Leader Media ReleaseCarolyn MillerFebruary 5, 2018Smart Sparrow, Michelle Deaker, Grant Chamberlain
Find-me appoints Rachel Boden as new CEO Media ReleaseCarolyn MillerFebruary 5, 2018Find-Me Technologies, Anne-Marie Birkill
Citadel Group aquires OneVentures portfolio company Charm Health Media ReleaseCarolyn MillerSeptember 4, 2017Anne-Marie Birkill, Charm Health
OneVentures Boosts Healthcare Team Media ReleaseCarolyn MillerMay 29, 2017OneVentures, Paul Kelly, Anne-Marie Birkill, Michelle Deaker
OneVentures makes first investment for the Biomedical Translation Fund Media ReleaseCarolyn MillerMay 27, 2017Prota Therapeutics, Anne-Marie Birkill, Paul Kelly, Michelle Deaker
